SAYDAM, G. Et Al. 2014. Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update. BLOOD , vol.124, no.21 .

SAYDAM, G., HAZNEDAROĞLU, İ. C., KAYNAR, L., Yavuz, A., Ali, R., GÜVENÇ, B., ... AKAY, O. M.(2014). Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update. BLOOD , vol.124, no.21.

SAYDAM, GÜRAY Et Al. "Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update," BLOOD , vol.124, no.21, 2014

SAYDAM, GÜRAY Et Al. "Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update." BLOOD , vol.124, no.21, 2014

SAYDAM, G. Et Al. (2014) . "Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update." BLOOD , vol.124, no.21.

@article{article, author={GÜRAY SAYDAM Et Al. }, title={Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update}, journal={BLOOD}, year=2014}